药物对比
Insulin Aspart Human vs Troglitazone
比较Insulin Aspart（速效注射用胰岛素）和Troglitazone（因肝风险已撤市的口服噻唑烷二酮类药物）。Insulin Aspart仍是糖尿病的标准治疗药物。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes who are considering oral medications versus injectable options may compare Insulin Aspart to the discontinued Troglitazone.
结论
Insulin Aspart is a viable and commonly prescribed treatment for diabetes, whereas Troglitazone has been removed from the market due to safety concerns.
全部药物对比